AQDOT LIMITED

Their core work

AQDOT is a Cambridge-based deep-tech SME working at the commercial frontier of supramolecular chemistry — specifically the design and application of molecular capsules (cage molecules) that function in aqueous, industrially relevant environments. Their core technology involves molecular containers capable of selectively binding, capturing, or neutralizing volatile organic compounds (VOCs) and odorous molecules in water-based systems. Their H2020 work moved rapidly from foundational research into capsule properties to a specific commercial product line in high-performance odor and VOC management. As an early-stage spin-out operating in 2017–2018, they were translating what is typically academic-only chemistry into scalable, commercially deployable applications.

What they specialise in

How they've shifted over time

Both projects fall within a narrow 12-month window (2017–2018), so no multi-year keyword shift is observable. What can be traced is a logical internal progression: AqPDRA (2017) investigated the fundamental properties of molecular capsules in commercial media — a feasibility and characterisation phase — while AqFresh (2018) applied that knowledge directly to a defined market problem, odour and VOC control. This compressed arc from materials science to product suggests the organization was moving fast toward commercialisation rather than building a research base.

AQDOT was on a rapid commercialisation path, translating cage chemistry into a specific industrial product — suggesting any future collaboration would be product- and market-focused, not basic-research-focused.

How they like to work

AQDOT coordinated both H2020 projects with no recorded consortium partners — entirely consistent with SME Instrument Phase 1 grants, which are structured as solo company feasibility studies. This means there is no documented EU co-operation network to read, and they have operated as a self-contained unit rather than as a consortium builder. Working with them in a future consortium would likely mean engaging them as a technology provider bringing proprietary chemistry, not as an experienced multi-partner coordinator.

No consortium partners are recorded in the H2020 dataset, which is expected for SME Instrument Phase 1 projects. AQDOT's Cambridge base places them near one of Europe's densest chemistry research ecosystems, but no formal EU-funded international partnerships are documented.

What sets them apart

AQDOT occupies a narrow but commercially attractive niche: molecular cage chemistry that works in water and at industrial scale, rather than in the organic solvents typical of academic supramolecular research. The dual application of the same platform — both for industrial characterisation (AqPDRA) and for a consumer-facing odour product (AqFresh) — signals platform technology with cross-market reach. For a consortium builder, they represent a Cambridge-pedigreed deep-tech SME with proprietary molecular encapsulation IP rather than a services or consulting profile.

Highlights from their portfolio

• AqPDRA
  The foundational project (and largest single grant at EUR 68,408), establishing the scientific basis for AQDOT's molecular capsule platform in commercially relevant aqueous media.
• AqFresh
  Demonstrates rapid pivot from materials research to a named commercial product in odour and VOC management, confirming the platform's multi-application potential.